Zhongxing X. Liao

机构：The University of Texas MD Anderson Cancer Center, Thoracic Surgery Foundation, Radiation Oncology Institute, Radiation Oncology Associates · ORCID：0000-0002-2224-9478

发表论文 906 篇 · 总被引 28583 次 · h-index 94

代表论文

• Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial (2025 · The Lancet · 被引 41)
• Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer (2025 · Cancer Discovery · 被引 18)
• Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC (2025 · Nature Communications · 被引 11)
• Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial (2025 · Journal for ImmunoTherapy of Cancer · 被引 6)
• Multiomic based Bayesian network toxicity modeling for simultaneous prediction of multiple toxicity outcomes in NSCLC (2025 · Radiotherapy and Oncology · 被引 6)
• Pretreatment Risk Model for Radiation-Induced Lymphopenia Is Associated With Adjuvant Durvalumab Efficacy in Patients With Unresectable Stage III NSCLC (2026 · International Journal of Radiation Oncology*Biology*Physics · 被引 5)